Oxidative Stress as “Mother” of Many Human Diseases at Strong Clinical Impact
Article Sidebar
Main Article Content
Abstract
Oxidative stress, characterized by the production in excess of free radicals, is the main aspect of all living systems which use oxygen to convert biochemical energy coming from nutrients into adenosine triphosphate. In turn free radicals, also called reactive oxygen species , induce oxidative damage to some cellular macromolecules, as lipids, proteins, and DNA .Increased reactive oxygen species serum concentration has been implicated in the pathogenesis of some, common human diseases, included both healthy and diseased ageing. The most frequent pathologies involved are: atherosclerosis, cancer, Alzheimer's and Parkinson's Diseases and chronic obstructive pulmonary disease. Together with these, other, less frequent diseases can be interested, as chronic fatigue syndrome, lateral amyotrophic sclerosis and skin diseases. Therefore oxidative stress, that is an imbalance of an essential biochemical reaction physiologically happening in the human body, can be considered as one of the sources of the most common human pathologies and of the aging process.
Downloads
Article Details
Copyright (c) 2016 Cacciapuoti F.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.
We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.
Peertechz accomplice with- [CC BY 4.0]
Explanation
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:
|
License Name |
Permission to read and download |
Permission to display in a repository |
Permission to translate |
Commercial uses of manuscript |
|
CC BY 4.0 |
Yes |
Yes |
Yes |
Yes |
The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.
Sies H. Oxidative stress: introductory remarks. In: Sies H (ed.)-Oxidative stress-Academic Press. 1985; 1-7 .
Yoshikawa T, Naito Y. What is oxidative stress? JMAJ 2002; 45: 271-276 .
Bannister J. B.H.P.O. Free radicals in Biology and Medicine 2007; 10: 250-266.
Sosa V, Moliné T, Somoza R, Paciucci R, Kondoh H, et al. Oxidative stress and cancer: an overview. Ageing Res Rev. 2013; 12: 376-390.
Ray PD, Huang BW, Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal. 2012; 24: 981-990.
Dai DF, Chiao YA, Marcinek DJ, Szeto HH, Rabinovitch PS. Mitochondrial oxidative stress in aging and healthspan. Longev Healthspan. 2014; 3: 6.
Aruoma OI. Free radicals, oxidative stress, and antioxidants in human health disease. J Amer Oil Chemical Soc 1998; 75: 199-212 .
Klaunig JE, Kamendulis LM, Hocevar BA. Oxidative stress and oxidative damage in carcinogenesis. Toxicol Pathol. 2010; 38: 96-109.
Halliwell B. Can oxidative DNA damage be used as a biomarker of cancer risk in humans? Problems, resolutions and preliminary results from nutritional supplementation studies. Free Radic Res. 1998; 29: 469-486.
Noda N, Wakasugi H. Cancer and oxidative stress. JMAJ. 2001; 44: 535-539 .
Cacciapuoti F. Oxidative stress such as basic reaction of many among human diseases and ageing. Trends in Med 2010; 10: 191-197 .
Vogiatzi G, Tousoulis D, Stefanadis C. The role of oxidative stress in atherosclerosis. Hellenic J Cardiol. 2009; 50: 402-409.
Klaunig JE, Kamendulis LM. The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol. 2004; 44: 239-267.
Henriksen EJ, Diamond-Stanic MK, Marchionne EM. Oxidative stress and the etiology of insulin resistance and type 2 diabetes. Free Radic Biol Med. 2011; 51: 993-999.
Aroor AR, DeMarco VG. Oxidative stress and obesity: the chicken or the egg? Diabetes. 2014; 63: 2216-2218.
Madeo J, Elsayad C. The role of oxidative stress in Alzheimer's disease. Alzheimer's and Parkinsonism. 1985; 3: 2 .
Hwang O. Role of oxidative stress in Parkinson's disease. Exp Neurobiol. 2013; 22: 11-17.
Fulle S, Pietrangelo T, Mancinelli R, Saggini R, Fanò G. Specific correlations between muscle oxidative stress and chronic fatigue syndrome: a working hypothesis. J Muscle Res Cell Motil. 2007; 28: 355-362.
Cavalcante AG, de Bruin PF. The role of oxidative stress in COPD: current concepts and perspectives. J Bras Pneumol. 2009; 35: 1227-1237.
Herman D. Aging a theory based on free radical and radiation chemistry. J Gerontol. 1956; 11: 296-300 .
Abdollahi M, Moridani MY, Aruoma OI, Mostafalou S. Oxidative stress in aging. Oxid Med Cell Longev. 2014; 2014: 876834.
Madamanchi NR, Vendrov A, Runge MS. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol. 2005; 25: 29-38.
Lum H, Roebuck KA. Oxidant stress and endothelial cell dysfunction. Am J Physiol Cell Physiol. 2001; 280: C719-741.
Harrison D, Griendling KK, Landmesser U, Hornig B, Drexler H. Role of oxidative stress in atherosclerosis. Am J Cardiol. 2003; 91: 7A-11A.
Donato AJ, Eskurza I, Silver AE, Levy AS, Pierce GL, et al. Direct evidence of endothelial oxidative stress with aging in humans. Relations to impaired dependent dilation and up-regulation of nuclear factor-kappaB. Circ Res. 2007; 106: 1659-1666 .
Bourcier T, Sukhova G, Libby P. The nuclear factor kappa-B signaling pathway participates in dysregulation of vascular smooth muscle cells in vitro and in human atherosclerosis. J Biol Chem. 1997; 272: 15817-15824.
Singh U, Devaraj S, Jialal I. Vitamin E, oxidative stress, and inflammation. Annu Rev Nutr. 2005; 25: 151-174.
Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest. 1996; 98: 2572-2579.
Tousoulis D, Antoniades C, Stefanadis C. Assessing inflammatory status in cardiovascular disease. Heart. 2007; 93: 1001-1007.
Tousoulis D, Antoniades C, Stefanadis C. Statins and antioxidant vitamins: should co-administration be avoided? J Am Coll Cardiol. 2006; 47: 1237.
Marnett LJ. Oxyradicals and DNA damage. Carcinogenesis. 2000; 21: 361-370.
Ishikawa K, Takenaga K, Akimoto M, Koshikawa N, Yamaguchi A, et al. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science. 2008; 320: 661-664.
Waris G, Ahsan H. Reactive oxygen species: role in the development of cancer and various chronic conditions. J Carcinog. 2006; 5: 14.
Wiemer EA. Stressed tumor cell, chemosensitized cancer. Nat Med. 2011; 17: 1552-1554.
Lee DJ, Kang SW. Reactive oxygen species and tumor metastasis. Mol Cells. 2013; 35: 93-98.
Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995; 1: 27-31.
Fei J, Hong A, Dobbins TA, Jones D, Lee CS, et al. Prognostic significance of vascular endothelial growth factor in squamous cell carcinomas of the tonsil in relation to human papillomavirus status and epidermal growth factor receptor. Ann Surg Oncol. 2009; 16: 2908-2917.
Tojo T, Ushio-Fukai M, Yamaoka-Tojo M, Ikeda S, Patrushev N, et al. Role of gp91phox (Nox2)-containing NAD(P)H oxidase in angiogenesis in response to hindlimb ischemia. Circulation. 2005; 111: 2347-2355.
Mathe E, Nguyen CH, Funamizu N, He P, Moake M, et al. Inflammation regulates microRNA expression in cooperation with p53 and nitric oxide. Journal of Cancer. 2012; 131: 760-765.
Mateescu B, Batista L, Cardon M, Gruosso T, de Feraudy Y, et al. miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response. Nat Med. 2011; 17: 1627-1635.
Favaro E, Ramachandran A, Mc Cormik R, Gee H, Blancher C, et al. MicroRNA-210 regulates mitochondrial free radical response to hypoxia and Krebs cycle in cancer cells by targeting iron Sulphur cluster protein. ISCU PLos One 2010; 5: e103345.
Watson J. Oxidants, antioxidants and the current incurability of metastatic cancers. Open Biol. 2013; 3: 120144.
Kovacic P, Jacintho JD. Mechanisms of carcinogenesis: focus on oxidative stress and electron transfer. Curr Med Chem. 2001; 8: 773-796.
Anderson EJ, Lustig ME, Boyle KE, Woodlief TL, Kane DA, Lin CT, Price JW 3rd. Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J Clin Invest. 2009; 119: 573-581.
Urakawa H, Katsuki A, Sumida Y, Gabazza EC, Murashima S, et al. Oxidative stress is associated with adiposity and insulin resistance in men. J Clin Endocrinol Metab. 2003; 88: 4673-4676.
Meigs JB, Larson MG, Fox CS, Keaney JF Jr, Vasan RS, et al. Association of oxidative stress, insulin resistance, and diabetes risk phenotypes: the Framingham Offspring Study. Diabetes Care. 2007; 30: 2529-2535.
Kim JS, Saengsirisuwan V, Sloniger JA, Teachey MK, Henriksen EJ. Oxidant stress and skeletal muscle glucose transport: roles of insulin signaling and p38 MAPK. Free Radic Biol Med. 2006; 41: 814-824.
Dokken BB, Saengsirisuwan V, Kim JS, Teakey MK, Henriksen EJ. Oxidative stress-induced insulin resistance in skeletal muscle: role of glycogen synthase kinase-3. Am J Physiol. Endocrinol. Metabol. 2008; 294: E615-E621.
Archuleta TL, Lemieux AM, Saengsirisuwan V, Teachey MK, et al. Oxidant stress-induced loss of IRS-1 and IRS-2 proteins in rat skeletal muscle: role of p38 MAPK. Free Radic Biol Med. 2009; 47: 1486-1493.
Youn JY, Siu KL, Lob HE, Itani H, Harrison DG, et al. Role of vascular oxidative stress in obesity and metabolic syndrome. Diabetes. 2014; 63: 2344-2355.
Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004; 114: 1752-1761.
Aroor AR, DeMarco VG. Oxidative stress and obesity: the chicken or the egg? Diabetes. 2014; 63: 2216-2218.
Murri M, Garcia-Fuentes E, Garcia-Almeida JM, Garrido-Sanchez L, Mayas MD, et al. Changes in oxidative stress and insulin resistance in morbidity obese patients after bariatric surgery. Obes Surg. 2010; 20: 323-368.
Perry G, Cash AD, Smith MA. Alzheimer Disease and Oxidative Stress. J Biomed Biotechnol. 2002; 2: 120-123.
Greenough MA, Camakaris J, Bush AI. Metal dyshomeostasis and oxidative stress in Alzheimer's disease. Neurochem Int. 2013; 62: 540-555.
Silva DF, Selfridge JE, Lu J, E L, Cardoso SM, et al. Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic intervention. Adv Pharmacol. 2012; 64: 83-126.
Reddy PH, Reddy TP. Mitochondria as a therapeutic target for aging and neurodegenerative diseases. Curr Alzheimer Res. 2011; 8: 393-409.
McManus MJ, Murphy MP, Franklin JL. The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer's disease. J Neurosci. 2011; 31: 15703-15715.
Yao H, Rahman I. Perspectives on translational and therapeutic aspects of SIRT1 in inflammaging and senescence. Biochem Pharmacol. 2012; 84: 1332-1339.
Cacciapuoti F. Multiple effects of omega-3 P.U.F.A. on some important life processes. J Cardiol Ther. 2014; 10: 46-51.
Schapira AH, Jenner P. Etiology and pathogenesis of Parkinson's disease. Mov Disord. 2011; 26: 1049-1055.
Hwang O. Role of oxidative stress in Parkinson's disease. Exp Neurobiol. 2013; 22: 11-17.
Conway KA, Rochet JC, Bieganski RM, Lansbury PT Jr. Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science. 2001; 294: 1346-1349.
LaVoie MJ, Ostaszewski BL, Weihofen A, Schlossmacher MG, Selkoe DJ. Dopamine covalently modifies and functionally inactivates parkin. Nat Med. 2005; 11: 1214-1221.
Zafar KS, Inayat-Hussain SH, Ross D. A comparative study of proteasomal inhibition and apoptosis induced in N27 mesencephalic cells by dopamine and MG132. J Neurochem. 2007; 102: 913-921.
Zecca L, Zucca FA, Wilms H, Sulzer D. Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics. Trends Neurosci. 2003; 26: 578-580.
Qian L, Flood PM, Hong JS. Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy. J Neural Transm (Vienna). 2010; 117: 971-979.
Jenner P. Oxidative stress in Parkinson's disease. Ann Neurol. 2003; 53: S26-S38.
Shaw PJ, Ince PG, Falkous G, Mantle D. Oxidative damage to protein in sporadic motor neuron disease spinal cord. Ann Neurol. 1995; 38: 691-695.
Ferrante RJ, Browne SE, Shinobu LA, Bowling AC, Baik MJ, et al. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J Neurochem. 1997; 69: 2064-2074.
Beal MF, Ferrante RJ, Browne SE, Matthews RT, Kowall NW, et al. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann Neurol. 1997; 42: 644-654.
Fitzmaurice PS, Shaw IC, Kleiner HE, Miller RT, Monks TJ, et al. Evidence for DNA damage in amyotrophic lateral sclerosis. Muscle Nerve. 1996; 19: 797-798.
Barber SC, Mead RJ, Shaw PJ. Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target. Biochim Biophys Acta. 2006; 1762: 1051-1067.
Carri MT, Valle C, Bozzo F, Cozzolino M. Oxidative stress and mitochondrial damage: importance in non-SOS 1-ALS. Front Cell Neurosci. 2015; 9:
Harman D. Origin and evolution of the free radical theory of aging: a brief personal history, 1954–2009. Biogerontology. 2009; 10: 773-781.
Pérez VI, Bokov A, Van Remmen H, Mele J, Ran Q, et al. Is the oxidative stress theory of aging dead? Biochim Biophys Acta. 2009; 1790: 1005-1014.
Ristow M, Zarse K. How increased oxidative stress promotes longevity and metabolic health: The concept of mitochondrial hormesis (mitohormesis). Exp Gerontol. 2010; 45: 410-418.
Dai DF, Chiao YA, Marcinek DJ, Szeto HH, Rabinovitch PS. Mitochondrial oxidative stress in aging and healthspan. Longev Healthspan. 2014; 3: 6.
Gomez-Cabrera MC, Borras C, Pallardo FV, Sastre J, Li LL, et al. Decreasing xantine oxidase-mediated oxidative stress prevents useful cellular adaptation to exercise in rats. J Physiol. 2005; 567: 113-120.
Myung SK, Ju W, Cho B, Oh SW, Park SM, et al. Korean Meta-Analysis Study Group. Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials. BMJ. 2013; 346: f10.
Li FJ, Shen L, Ji HF. Dietary intakes of vitamin E, vitamin C, and β-carotene and risk of Alzheimer's disease: a meta-analysis. J Alzheimers Dis. 2012; 31: 253-258.
Manayi A, Saeidnia S, Gohari AR, Abdollahi M. Methods for the discovery of new anti-aging products--targeted approaches. Expert Opin Drug Discov. 2014; 9: 383-405.
Wyller VB. The chronic fatigue syndrome--an update. Acta Neurol Scand Suppl. 2007; 187: 7-14.
Holmes GP, Kaplan JE, Gantz NM, Komaroff AL, Schonberger LB, et al. Chronic fatigue syndrome: a working case definition. Ann Intern Med. 1988; 108: 387-389.
Smith J, Fritz EL, Kerr JR, Cleare AJ, Wessely S, et al. Association of chronic fatigue syndrome with human leucocyte antigen class II alleles. J Clin Pathol. 2005; 58: 860-863.
Kennedy G, Spence VA, McLaren M, Hill A, Underwood C, et al. Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. Free Radic Biol Med. 2005; 39: 584-589.
Fulle S, Belia S, Vecchiet J, Morabito C, Vecchiet L, et al. Modification of the functional capacity of sarcoplasmic reticulum membranes in patients suffering from chronic fatigue syndrome. Neuromuscul Disord. 2003; 13: 479-484.
Mecocci P. Fano' G, Fulle S, Mac Garvey U, Shinobu L, et al. Age-dependent increases in oxidative damage to DNA, lipids, and proteins in human skeletal muscle. Free Radic Biol Med. 1999; 26: 303-308.
Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J. 1977; 1: 1645-1648.
Lima ES, Abdalla DSP. Peroxidacao lipidica: mecanismos e avaliacao em amostras. Rev Bras Cinc Fam 2001; 37: 293-303.
Rolin S, Masereel B, Dogné JM. Prostanoids as pharmacological targets in COPD and asthma. Eur J Pharmacol. 2006; 533: 89-100.
Louhelainen N, Rytilà P, Haahtela T, Kinnula VL, DjukanoviÄ R. Persistence of oxidant and protease burden in the airways after smoking cessation. BMC Pulm Med. 2009; 9: 25.
Briganti S, Picardo M. Antioxidant activity, lipid peroxidation and skin diseases. What's new. J Eur Acad Dermatol Venereol. 2003; 17: 663-669.
Black HS. ROS: a step closer to elucidating their role in the etiology of light-induced skin disorders. J Invest Dermatol. 2004; 122: xiii-xiv.
Lü JM, Lin PH, Yao Q, Chen C. Chemical and molecular mechanisms of antioxidants: experimental approaches and model systems. J Cell Mol Med. 2010; 14: 840-860.